The Journal of Immunology, 1999, 162: 4115-4121.
Copyright © 1999 by The American Association of Immunologists
Cloning and Modeling of the First Nonmammalian CD41
Riitta Koskinen2,
,
Urpo Lamminmäki
,
Clive A. Tregaskes§,
Jan Salomonsen¶,
John R. Young§ and
Olli Vainio
*
Turku Immunology Center and Departments of
Medical Microbiology and
Biotechnology, Turku University, Turku, Finland;
§
Institute for Animal Health, Compton, United Kingdom; and
¶
Department of Virology and Immunology, Royal Veterinary and Agricultural University, Frederiksberg, Denmark
 |
Abstract
|
|---|
We have cloned and sequenced the first nonmammalian CD4 cDNA from
the chicken using the COS cell expression method. Chicken CD4 contains
four extracellular Ig domains that, in analogy to mammalian CD4, are in
the order V, C2, V, and C2. The molecule is 24% identical with both
human and mouse sequences. The extracellular domains were modeled using
human and rat CD4 crystal structures as templates. In the first domain
there are two extra Cys residues that are at suitable distance to form
an intra-ß-sheet disulfide bridge in addition to the canonical one in
the V domain. The region responsible for the interaction with MHC class
II is relatively nonconserved in chicken. However, there are positively
charged amino acids in the C'' region of the N-terminal domain that may
mediate the association to the negatively charged residues of the MHC
class II ß-chain. Molecular modeling also implies that the
membrane-proximal domain mediates dimerization of chicken CD4 in a
similar way as it does for human CD4. Furthermore, the cytoplasmic tail
is highly conserved, containing the protein tyrosine kinase
p56lck recognition site that is preceded
by an adjacent di-leucine motif for the internalization of the
molecule. Interestingly, there are no Ser residues in the cytoplasmic
part, which may explain the slow down-regulation of chicken CD4 after
phorbol ester stimulation.
 |
Introduction
|
|---|
CD4
is a single chain transmembrane glycoprotein on most thymocytes and on
a subset of T cells (1, 2). It has an essential role in thymocyte
development as well as in cell-mediated immune defense in mature T
cells. In the context of Ag recognition by the TCR, CD4 dimerizes and
binds to the
2 and ß2 domains of MHC class
II (3, 4, 5, 6, 7, 8). The interaction triggers a signal to the T cell that is
transduced by the protein tyrosine kinase
p56lck, which binds to a conserved site in
the cytoplasmic domain of CD4 (9, 10). Following T cell activation, CD4
is internalized (11, 12). This requires phosphorylation of cytoplasmic
Ser residues that are associated with the di-leucine motif (13, 14).
Furthermore, human CD4 is a part of the receptor complex for HIV gp120,
and the deficiency of CD4-positive cells plays a role in the
pathogenesis of AIDS (15). The three-dimensional structures of the
extracellular domains of human and rat CD4 have been determined,
revealing the structurally and functionally important features (7, 16, 17, 18, 19).
Here we describe the cloning of the first nonmammalian CD4 cDNA from
the chicken. We have also modeled the four extracellular domains of
chicken CD4 based on the known three-dimensional structures of human
and rat CD4. The model demonstrates that despite the low sequence
identity in chicken and mammalian CD4, several similar structural
features have remained conserved. Furthermore, our analyses imply that
chicken CD4 dimerizes in the same way as human CD4.
 |
Materials and Methods
|
|---|
Animals
Strain H.B2 chickens (B2 MHC haplotype) were from the colonies
of the Department of Medical Microbiology, Turku University (Turku,
Finland).
Abs and cell lines
mAb 2-6 (IgG1 isotype), 2-35 (IgG2b), 7-125 (IgG1), 9-11 (IgG1),
and 11-33 (IgM) against chicken CD4 were previously described (20, 21).
mAb CT4 was purchased from Southern Biotechnology Associates
(Birmingham, AL). mAb L22 (IgG1) and 11G2 (IgG1) detect the Bu-1a
and Bu-1b molecules, respectively (22). mAb 2-191 recognizes chicken
CD5 (IgG1) (23).
Mareks disease virus-transformed CD4+ T cell lines
MDCC-CU32 and MDCC-CU36 were gifts from Drs. B. W. Calnek and
K. A. Schat, Cornell University (Ithaca, NY). The
reticuloendotheliosis virus-transformed B cell line RECC-RP13 was a
gift from Dr. K. Nazerian, U.S. Department of Agriculture (East
Lansing, MI).
cDNA cloning and sequencing
A cDNA library was constructed from thymus (8-wk-old H.B2
chicken) mRNA. Transfections of COS-7 cells with the cDNA library and
isolation of the positive clone, p2.6, were performed as described
previously (23).
Nucleotide sequencing of the cDNA was conducted on both strands using
the Sequenase version 2.0 kit (United States Biochemical, Cleveland,
OH). Sequence data were analyzed by Genetics Computer Group software
(Madison, WI), Lasergene Molecular Biology software (DNASTAR, Madison,
WI), and Prosite pattern search (EMBL, Heidelberg, Germany)
programs.
Labeling and immunoprecipitation
Metabolic labeling and immunoprecipitation of transfected COS-7
cells were conducted as previously described (23). COS-7 cells were
transfected with p2.6 plasmid containing chicken CD4 cDNA. Cell lysate
was precleared with a mixture of mAb L22 and 11G2 and
immunoprecipitated with mAb 2-6 or anti-CD5-specific mAb 2-191.
Labeling of thymocytes from a 6-wk-old H.B2 chicken was performed using
the lactoperoxidase/glucose oxidase method followed by lysis,
immunoprecipitation, and analysis on 12% SDS-PAGE as described
previously (24, 25).
Northern hybridization
Northern blot hybridization was conducted with mRNA from H.B2
chicken thymus, bursa, spleen, Mareks disease virus-transformed
CD4+ T cell lines MDCC-CU32 and MDCC-CU36, and a
reticuloendotheliosis virus-transformed B cell line RECC-RP13. mRNA was
isolated using RNeasy and Oligotex mRNA Spin column kits (Qiagen,
Chatsworth, CA). After formaldehyde agarose (1.2%)-gel electrophoresis
the samples were transferred overnight to a nylon membrane
(Hybond-N+, Amersham, Aylesbury, U.K.). Prehybridization
and hybridization were performed in a solution containing 0.5% SDS,
5x Denhardts solution, 3x SSPE, 10% dextran sulfate, and 100
µg/ml salmon sperm DNA at 60°C for 6 h. Hybridization was
conducted at 60°C overnight with a total CD4 cDNA as a probe. The
1029-bp control probe of chicken ß-actin was prepared as previously
described (26). The probes were labeled with
[
-32P]dCTP (Amersham) using the Rediprime labeling kit
(Amersham). Hybridized membrane was washed in 2x SSC/1% SDS at 60°C
for 30 min and in 0.5x SSC/1% SDS at 60°C for 15 min followed by
autoradiography for 5 and 18 h.
Molecular modeling
A homology model of the two N-terminal domains of chicken CD4
was built with a HOMOLOGY program included in the Insight II program
package (Micron Separations, Westboro, MA). The sequence analysis was
made using the GCG program package followed by structural alignment of
several conserved molecules. For the V set domains 1 and 3, these
structures were human CD4 domains 1 and 3 (7, 16, 17), rat CD4 domain 3
(18), human CD8 (27), human CD2 (28), and Ig light chain variable
domain (REI) (29). For the C set domains, structures of human CD4
domain 2 and rat CD4 domain 4 were aligned (17, 18).
The two N-terminal domains were built using human CD4 and CD8 as
templates, whereas domains 3 and 4 were built on the rat CD4 template.
To combine the models, they were oriented by superimposing them on the
structure consisting of all four extracellular domains of human CD4
(7).
The model was energy minimized by program DISCOVER (Molecular
Simulation, Waltham, MA). First, the hydrogen atoms were allowed to
relax in a 20-step minimization using steepest decent algorithm. Then
100 steps of the steepest decent were run while keeping the C
atoms
of the ß-sheets constrained with a force of 50 kJ/mol/Å2
followed by another 100 steps of steepest decent and 100 steps of
conjugate gradient minimization without constraints. Finally, 200
steps of conjugate gradient minimization was performed with formal
charges on ionic groups. The CCFC force field and default parameters of
DISCOVER were used throughout the minimizations.
Dimerization
To study the potential dimerization interactions between the
chicken CD4 molecules, a dimer of the models was constructed. This was
performed by superimposing two chicken CD4 models on the structure of
human CD4 dimer using C
atoms of the ß-sheets on the interaction
area (residues 341345, 354358, 373378, and 386382 in chicken
and residues 314318, 324328, 342347, and 355361 in human CD4).
 |
Results and Discussion
|
|---|
Cloning and identification of an mAb 2-6-specific cDNA
We wanted to clone the cDNA encoding chicken CD4, because of the
essential importance of CD4 in both mammalian and avian immune defense.
Chicken CD4 has been demonstrated to share functional similarity to the
mammalian CD4 homologues (21, 30). Identification of the structure of
chicken CD4 will help to reveal evolutionarily important features of
the molecule.
To isolate the putative chicken CD4 cDNA, a chicken thymus cDNA library
in the pCDM8 expression vector was transfected into COS-7 cells.
Transfected cells were stained with mAb 2-6 supposed to detect chicken
CD4, and plasmids from a positive cell were isolated. After three
rounds of rescreening, a clone, p2.6, was isolated. It contained an
insert of 1990 bp containing an open reading frame of 1461 bp between
nucleotides 143 and 1603 (Fig. 1
). The 3'
untranslated region contains a putative polyadenylation signal followed
by a poly(A) tail. The protein encoded by the open reading frame
consists of a 402-amino acid extracellular region including four
Ig-like domains, a 24-residue hydrophobic transmembrane region, and a
33-residue cytoplasmic tail. Protein database searches with the
predicted amino acid sequences resulted in highest homology, with
mammalian CD4 sequences showing 24% identity to both mouse and human
sequences. Furthermore, COS cells transfected with p2.6 stained with
several proposed anti-chicken CD4 mAb, 2-35, 7-125, 9-11, 11-33,
and CT4, but COS cells transfected with a control cDNA did not react
with the Abs (data not shown). In addition, a 64-kDa band was
immunoprecipitated from metabolically labeled transfected COS cells
with mAb 2-6, but not with a control mAb 2-191 recognizing chicken CD5
(Fig. 2
A). This demonstrates
that p2.6-transfected COS cells produce a protein similar to that
precipitated from chicken T cells (Fig. 2
B).

View larger version (78K):
[in this window]
[in a new window]
|
FIGURE 1. Nucleotide sequence of chicken CD4 cDNA and predicted amino acid
sequence. Potential N-glycosylation sites, the
transmembrane region, and a putative polyadenylation site are
underlined. Numbers on the left indicate the locations
of nucleotides, and those on the right indicate amino
acids. The putative signal peptide is between residues -28 and -1.
The mature polypeptide starts at +1. These sequence data are available
from EMBL under accession number Y12012.
|
|

View larger version (64K):
[in this window]
[in a new window]
|
FIGURE 2. Immunoprecipitation of chicken CD4. A,
35S-labeled p2.6-transfected COS cell lysate was
immunoprecipitated with mAb 2-6 or control mAb 2-191 against chicken
CD5. The precipitated material was analyzed on 12% SDS-PAGE under
reducing conditions. The migrations of m.w. standards are indicated to
the left. B, Chicken thymocytes were
surface 125I-labeled, lysed, and immunoprecipitated with
mAb 2-6 or control supernatant from Sp2/0 cells. The samples were run
on 12% SDS-PAGE under reducing conditions. The migrations of m.w.
standards are indicated to the right.
|
|
Northern blot analysis with a CD4 cDNA probe revealed a single 2.2-kb
transcript in thymus, spleen, and CD4-expressing T cell lines MDCC-CU32
and MDCC-CU36 (Fig. 3
). No CD4
transcripts were detected in the bursa or in a B cell line, RECC-RP13.
In spleen the transcript was expressed at a much lower level than in
thymus.

View larger version (51K):
[in this window]
[in a new window]
|
FIGURE 3. Northern blot hybridization. The expression of the CD4 mRNA in
indicated chicken tissues and cell lines was detected using total CD4
cDNA as a probe. The exposition time for thymus and cell lines was
5 h; that for bursa and spleen was 18 h. The chicken
ß-actin probe was used to assess the amount of mRNA.
|
|
Analysis of the extracellular domains of chicken CD4
The putative signal peptide of chicken CD4 is 28 amino acids
long. Its cleavage site was predicted by the rules of von Heijne (31)
and by comparison with mammalian CD4 sequences. The predicted m.w. of
the mature polypeptide is 52,039, and the isoelectric point is 10.1.
The chicken CD4 amino acid sequence was compared with the mammalian
sequences, and the extracellular part was modeled based on the known
three-dimensional structures of human and rat CD4 (7, 16, 17, 18, 19). The
sequence alignment suggests that the extracellular region of chicken
CD4 consists of four Ig domains in the order V, C2, V, and C2, like
mammalian CD4 (Fig. 4
). In general, the
modeled structure of chicken CD4 conformed readily to the mammalian CD4
structure (Fig. 5
). The deletions and
insertions could be accounted for within the loops of the modeled
structure, enabling preservation of the basic Ig domain structure. The
two N-terminal domains have been of major interest, since they mediate
both the binding of MHC class II molecule and the HIV gp120 (8, 32).
Recently, the membrane-proximal domain was shown to participate in CD4
dimerization during Ag recognition by the TCR (7).

View larger version (61K):
[in this window]
[in a new window]
|
FIGURE 4. Structurally based alignment of chicken CD4 amino acid sequence with
human, mouse, and rat CD4 sequences. The ß strands of V set domains 1
and 3 are marked with ABCC'C''DEFG, and those of C set domains 2 and 4
are marked with ABCC'EFG. The numbered lines above the sequence
indicate the ß strands of the particular domain, a bar shows the
transmembrane region, and a line indicates the
p56lck recognition site. Extra cysteines in
the first domain are marked with an asterisk. An identical amino acid
to the chicken sequence is shown as a dot, and a gap is shown as a
dash. Numbers on the right indicate the location of the
amino acid residue of the corresponding CD4 sequence.
|
|

View larger version (45K):
[in this window]
[in a new window]
|
FIGURE 5. A stereo picture of the four extracellular domains of chicken and
human CD4. The chicken sequence is in black, and the human sequence is
in red. A circle indicates a putative N-glycosylation
site. The model is built using human and rat CD4 crystal structures as
templates (7, 17, 19).
|
|
The typical Ig V domain features of the first domain are well
conserved. The canonical disulfide bridge between Cys residues in the B
and F strands is conserved as well as the Trp in the C strand (Fig. 2
).
The characteristic pattern for Ig and TCR V domain,
Asp-X-Gly/Ala-X-Tyr-X-Cys, precedes the ß strand F (33). The Gly/Ala
is not found in human and mouse sequences. The Asp is at a suitable
distance to form a salt bridge with the Arg of the D strand (at
position 54) in human CD4, as well as with Arg58 in chicken
CD4. There are two extra Cys residues in strands C and F at positions
27 and 85, respectively, that, according to the modeling, can form an
extra intra-ß-sheet disulfide bridge (Fig. 6
). Thus, the structural features make
the first domain a typical V-like domain with the exception of an extra
disulfide bridge.

View larger version (110K):
[in this window]
[in a new window]
|
FIGURE 6. The N-terminal domain of chicken CD4 (left) and human
CD4 (right). The chicken domain is built using the
corresponding human structure as template (17). The C'/C'' and C''/D
loops are marked in both chicken and human structures. The disulfide
bridges are colored yellow. The important amino acids involved in MHC
class II binding are shown.
|
|
In the second domain of chicken CD4 the F strand Cys is conserved, but
the Cys located noncanonically in the C strand of many mammalian CD4s
(at position 130 in the human) is replaced by an Ile residue (Fig. 2
).
This Cys is substituted by a Trp in cat, dog, and rabbit CD4 sequences
also (34, 35, 36). Similarly to the human and mouse CD4 there is no
disulfide bridge in the third domain of chicken CD4 (Fig. 4
). However,
the F strand of chicken CD4 contains a typical Ig V domain Tyr and a
Cys that are not found in mammalian sequences. Instead, the C strand
Trp is conserved. In the fourth domain the conserved Cys residues in
strands B and F form a typical disulfide bridge (Fig. 4
). The Ig
domain-specific Trp is found in chicken CD4 (at position 344), but is
replaced by a Leu residue in human, mouse, and rat. A long loop with
9-residue insertion between A and B strands obviously is located near
the membrane (Figs. 4
and 5
).
The domain joining sequences are well conserved, suggesting their
importance in the maintenance and changes of CD4 conformation
(Fig. 4
). As in mammals, the G strand of the first domain is directly
followed by the A strand of the second domain. The hinge region between
the second and third domains containing a conserved Val-Leu-Gly-Phe has
an essential importance for the conformation, enabling the
bending of the molecule (8). The G/A strands connecting domains 3 and 4
have a fully conserved tetrapeptide, Leu-Val-Val-Met, forming the core
of the G/A junction. Thus, the structural relationship of these domains
is exceptionally conserved in the chicken, implying a strong selective
pressure. In summary, the extracellular region of chicken CD4, while
having a low level of conservation at the amino acid sequence level,
has nevertheless conserved several structural features of the mammalian
CD4s. It has also retained some typical Ig superfamily (IgSF) domain
features that are absent in mammals.
The high carbohydrate content of chicken CD4 indicates that several of
the seven potential N-glycosylation sites are used (21)
(Figs. 1
and 5
). They form a specific nonconserved glycosylation
pattern of chicken CD4 not found in other species. There are three
possible N-glycosylation sites in the membrane-proximal
domain and two in both the second and third domains (Fig. 5
). Human CD4
has only two potential N-glycosylation sites, one each in
the third and fourth domains (2). Mouse CD4 has four glycosylation
sites and rat CD4 has three that are identical with those in the mouse
(37, 38).
Putative molecular interactions of chicken CD4
According to several studies the binding of human CD4 to MHC
class II is mediated by residues on a broad area in the first
IgSF domain and some residues in the second domain (39, 40, 41, 42, 43, 44, 45). The
interacting amino acids are situated on either side of the molecule,
including the C''/D region amino acids Phe43,
Lys46, and Arg59 of the first domain on one
side (Fig. 6
). In the chicken only Lys50 is conserved, but
there is also a solvent-exposed Phe at position 49 close to the
corresponding location of Phe43 in human CD4 (Figs. 4
and 6
). In addition, the insertion and deletion in the C/C' loop and the
D/E loop, respectively, may affect the conformation of this region in
chicken CD4. However, on the same face around the C'' region positively
charged residues, Lys45, Lys50, and
Lys52, could associate with negatively charged Glu residues
on MHC class II ß-chain that have been shown to be involved in CD4
binding (Fig. 6
) (46). In human CD4 there are also several positively
charged, surface-exposed residues in this region, like
Lys46 and Arg59, that may interact with the
negatively charged amino acids of the MHC class II. The role of the
charge interactions in the binding affinity of CD4 and MHC class II
remains to be solved.
On the opposite side of the C''/D region of the first domain of human
CD4 there are solvent-exposed residues Ser19 and
Gln89 and in the second domain there is Gln165
(Fig. 4
) that are found to mediate CD4/MHC class II association (47, 48). These residues are not conserved in the chicken. Molecular
interactions mediating CD4/MHC class II association on this side of
chicken CD4 remain to be clarified.
The amino acids of human CD4 involved in HIV gp120 binding are located
mainly near the C'-D region of the first domain (47, 48, 49, 50, 51, 52, 53). Here the
chicken CD4 structure is grossly similar (Fig. 4
). However, its
conformation can be affected by the three-residue insertion in the
adjacent C/C' loop and the five-residue deletion in the neighboring D/E
loop, which still has potential residues for gp120 interaction in human
sequence. In addition, the natures of several surface-exposed residues
are different, presumably hindering the recognition of chicken CD4 by
the virus.
The dimerization of human CD4 through the membrane-proximal domains
involves the C/C' loop together with the F and G strands (7). The
superimposition of the two chicken CD4 molecules on the human dimeric
structure results in a similar clasped hands-like interaction of the
concave surfaces (Fig. 7
). The
replacement of Gln344, which is absolutely conserved in
mammals, by a shorter Asn375 in the chicken results in loss
of the pairwise contact between these residues in the middle of the
interface. However, analysis of the contacts mediating possible
dimerization shows that several residues from the interacting molecules
contact each other (Fig. 7
A). Leu residues at position 373
seem to have a pairwise hydrophobic interaction similar to that of the
corresponding residue Met342 in the human CD4 dimer. The
side chains of Lys384 and Glu345 are at a
suitable distance for charge-charge interaction. Correspondingly,
Lys318 and Glu356 possibly form two pairwise
salt bridges in the human dimer (7). Met352 from the C/C'
loop seems to pack against residues Ile386 and
Ser387 in the G strand of the other molecule. Moreover,
Asn348 may interact with Asn389 in the other
molecule through hydrogen bonding. Interestingly, both these Asn
residues are potential glycosylation sites and are located on the edge
of the interaction region. Since these residues from the two molecules
are located close to each other in the dimer model, the attachment of a
bulky carbohydrate side chain in both of them would result in serious
steric hindrance if the dimerization took place in a similar way as
that for human CD4. It is most likely that even the glycosylation of
Asn389 alone would hinder the dimerization because it is
mostly buried in dimer structure (Fig. 5
). However, Asn348
in the CC' loop is exposed and thus is probably able to accommodate a
carbohydrate group. Several plausible interactions, although not very
conserved with the human structure, can be observed when supposing a
similar dimerization pattern for chicken CD4 as that used for human
CD4.

View larger version (61K):
[in this window]
[in a new window]
|
FIGURE 7. A stereo view of the potential dimer interface at the membrane-proximal
domain of chicken (A) and human (B) CD4.
Side chains are shown for residues able to mediate dimerization.
|
|
The cytoplasmic region
The cytoplasmic tail has a relatively high homology to mammalian
CD4 sequences, with 55 and 52% identities to human and mouse
sequences, respectively. The region starting from Arg427 is
five amino acids shorter than those in human, mouse, and rat CD4 (Fig. 4
). It contains the highly conserved protein tyrosine kinase
p56lck recognition site KKTCQC (Fig. 4
)
(10, 54). Chicken CD4 has been shown to interact with a cellular
tyrosine kinase homologous to mammalian
p56lck (55). In chicken the
p56lck binding site is also preceded by a
di-leucine motif involved in Ag-induced CD4 internalization in the
human (13, 14, 56). The internalization requires phosphorylation of the
cytoplasmic Ser residues (11, 12, 13). Interestingly, the chicken CD4
sequence does not have the Ser residues that are conserved in mammals
(at positions 408 and 415 in human). Their absence may explain the slow
down-regulation of chicken CD4 after phorbol ester stimulation (21).
Instead, there are two Tyr residues (one of them adjacent to the
di-leucine motif) whose phosphorylation may replace the lacking
phosphoserines (Fig. 4
).
Conclusion
We have cloned the first nonmammalian CD4 from the chicken. The
composition of the extracellular Ig domains of chicken CD4 as well as
the highly conserved cytoplasmic region imply functional mechanisms
that have remained conserved across evolutionarily distant species.
 |
Acknowledgments
|
|---|
We thank Ann Sofie Hakulinen, Aija Kaitaranta, and Reija Venho for
their excellent technical assistance; Drs. Bruce W. Calnek,
Karel A. Schat, and Kevyan Nazerian for the cell lines; Drs.
Paavo Toivanen, Mikael Skurnik, Jari Jalava, and Jussi Liippo for
discussions; Eija Nordlund and Tuula Närä for secretarial
help; and Teuvo Virtanen for help in computing.
 |
Footnotes
|
|---|
1 This work was supported by the Academy of Finland, the Turku University Foundation, and the Human Frontier Science Program (Grant RG 366/96 to O.V.) and by the Danish National Science Research Council (Grants 9401634/9502172 to J.S.). 
2 Address correspondence and reprint requests to Dr. Riitta Koskinen, Turku Immunology Center and Department of Medical Microbiology, Kiinamyllynkatu 13, 20520 Turku, Finland. 
Received for publication September 22, 1998.
Accepted for publication December 22, 1998.
 |
References
|
|---|
-
Parnes, J. R.. 1989. Molecular biology and function of CD4 and CD8. Adv. Immunol. 44:265.[Medline]
-
Maddon, P. J., D. R. Littman, M. Godfrey, D. E. Maddon, L. Chess, R. Axel. 1985. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell 42:93.[Medline]
-
Doyle, C., J. L. Strominger. 1987. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 330:256.[Medline]
-
Cammarota, G., A. Scheirle, B. Takacs, D. M. Doran, R. Knorr, W. Bannwarth, J. Guardiola, F. Sinigaglia. 1992. Identification of a CD4 binding site on the ß2 domain of HLA-DR molecules. Nature 356:799.[Medline]
-
Sakihama, T., A. Smolyar, E. L. Reinherz. 1995. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. Proc. Natl. Acad. Sci. USA 92:6444.[Abstract/Free Full Text]
-
König, R., X. Shen, R. N. Germain. 1995. Involvement of both major histocompatibility complex class II
and ß chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 182:779.[Abstract/Free Full Text]
-
Wu, H., P. D. Kwong, W. A. Hendrickson. 1997. Dimeric association and segmental variability in the structure of human CD4. Nature 387:527.[Medline]
-
Huang, B., A. Yachou, S. Fleury, W. A. Hendrickson, R.-P. Sekaly. 1997. Analysis of the contact sites on the CD4 molecule with class II MHC molecule. J. Immunol. 158:216.[Abstract]
-
Veillette, A., M. A. Bookman, E. M. Horak, L. E. Samelson, J. Bolen. 1989. Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck. Nature 338:257.[Medline]
-
Glaichenhaus, N., N. Shastri, D. R. Littman, J. M. Turner. 1991. Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells. Cell 64:511.[Medline]
-
Shin, J., C. Doyle, Z. Yang, D. Kappes, J. L. Strominger. 1990. Structural features of the cytoplasmic region of CD4 required for internalization. EMBO J. 9:425.[Medline]
-
Acres, R. B., P. J. Conlon, D. Y. Mochizuki, B. Gallis. 1986. Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen. J. Biol. Chem. 261:16210.[Abstract/Free Full Text]
-
Shin, J., R. L. Dunbrack, S. Lee, J. L. Strominger. 1991. Phosphorylation-dependent down-modulation of CD4 requires a specific structure within the cytoplasmic domain of CD4. J. Biol. Chem. 266:10658.[Abstract/Free Full Text]
-
Dietrich, J., X. Hou, A-M. Wegener, C. Geisler. 1994. CD3
contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor. EMBO J. 13:2156.[Medline]
-
Siliciano, R. F.. 1996. The role of CD4 in HIV envelope-mediated pathogenesis. D. R. Littman, ed. The CD4 Molecule 159. Springer, Heidelberg.
-
Wang, J., Y. Yan, T. P. J. Garrett, J. Liu, D. W. Rodgers, R. L. Garlick, G. E. Tarr, Y. Husain, E. L. Reinherz, S. C. Harrison. 1990. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 348:411.[Medline]
-
Garrett, T. P. J., Y. Wang, J. Liu Yan, S. C. Harrison. 1993. Refinement and analysis of the structure of the first two domains of human CD4. J. Mol. Biol. 234:763.[Medline]
-
Brady, R. L., E. J. Dodson, G. Lange, S. J. Davis, A. F. Williams, A. N. Barclay. 1993. Crystal structure of domains 3 and 4 of rat CD4: relation to the NH2-terminal domains. Science 260:979.[Abstract/Free Full Text]
-
Lange, G., S. J. Lewis, G. N. Murshudov, G. G. Dodson, P. C. E. Moody, J. P. Turkenburg, A. N. Barclay, R. L. Brady. 1994. Crystal structure of an extracellular fragment of the rat CD4 receptor containing domains 3 and 4. Structure 2:469.[Medline]
-
Vainio, O., B. Riwar, O. Lassila. 1989. Characterization of chicken CD4-expressing cells. B. S. Bohogad, and G. Koch, eds. Recent Advances in Avian Immunology 45. A. R. Liss, New York.
-
Luhtala, M., J. Salomonsen, Y. Hirota, T. Onodera, P. Toivanen, O. Vainio. 1993. Analysis of chicken CD4 by monoclonal antibodies indicates evolutionary conservation between avian and mammalian species. Hybridoma 12:633.[Medline]
-
Veromaa, T., O. Vainio., E. Eerola, P. Toivanen. 1998. Monoclonal antibodies against chicken Bu-1a and Bu-1b alloantigens. Hybridoma 7:41.
-
Koskinen, R., T. W. Göbel, C. A. Tregaskes, J. R. Young, O. Vainio. 1998. The structure of avian CD5 implies a conserved function. J. Immunol. 160:4943.[Abstract/Free Full Text]
-
Kaufman, J. F., M. F. Flajnik, L. DuPasquier, P. Riegert. 1985. Xenopus MHC class II molecules. I. Identification and structural characterization. J. Immunol. 134:3248.[Abstract]
-
Luhtala, M., R. Koskinen, P. Toivanen, O. Vainio. 1995. Characterization of chicken CD8-specific monoclonal antibodies recognizing novel epitopes. Scand. J. Immunol. 42:171.[Medline]
-
Liippo, J., O. Lassila. 1997. Avian Ikaros gene is expressed early in embryogenesis. Eur. J. Immunol. 27:1853.[Medline]
-
Leahy, D. J., R. Axel, W. A. Hendrickson. 1992. Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 Å resolution. Cell 68:1145.[Medline]
-
Bodian, D. L., E. Y. Jones, K. Harlos, D. I. Stuart, S. J. Davis. 1994. Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 Å resolution. Structure 2:755.[Medline]
-
Epp, O., P. Colman, H. Fehlhammer, W. Bode, M. Schiffer, R. Huber, W. Palm. 1974. Crystal and molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI. Eur. J. Biochem. 45:513.[Medline]
-
Chan, M. M., C. L. Chen, L. L. Ager, M. D. Cooper. 1988. Identification of the avian homologues of mammalian CD4 and CD8 antigens. J. Immunol. 140:2133.[Abstract]
-
Von Heijne, G.. 1986. A new method for predicting signal sequence cleavage sites. Nucleic Acids Res. 14:4683.[Abstract/Free Full Text]
-
Landau, N. R., M. Warton, D. R. Littman. 1988. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature 334:159.[Medline]
-
Meisner, H., M. P. Czech. 1995. Immunoglobulin (Ig) superfamily. A. N. Barclay, and M. L. Birkeland, and M. H. Brown, and A. D. Beyers, and S. J. Davis, and C. Somoza, and A. F. Williams, eds. The Leukocyte Antigen Facts Book 54. Academic Press, San Diego.
-
Norimine, J., T. Miyazawa, Y. Kawaguchi, Y. Tohya, C. Kai, T. Mikami. 1992. A cDNA encoding feline CD4 has a unique repeat sequence downstream of the V-like region. Immunology 75:74.[Medline]
-
Gorman, S. D., M. R. Frewin, S. P. Cobbold, H. Waldmann. 1994. Isolation and expression of cDNA encoding the canine CD4 and CD8
antigens. Tissue Antigens 43:184.[Medline]
-
Hague, B. F., S. Sawasdikosol, T. J. Brown, K. Lee, D. P. Recker, T. J. Kindt. 1992. CD4 and its role in infection of rabbit cell lines by human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89:7963.[Abstract/Free Full Text]
-
Tourvieille, B., S. D. Gorman, E. H. Field, T. Hunkapiller, J. L. Parnes. 1986. Isolation and sequence of L3T4 complementary DNA clones: expression in T cells and brain. Science 234:610.[Abstract/Free Full Text]
-
Clark, S. J., W. A. Jefferies, A. N. Barclay, J. Gagnon, A. F. Williams. 1987. Peptide and nucleotide sequences of rat CD4 (W3/25) antigen: evidence for derivation from a structure with four immunoglobulin-related domains. Proc. Natl. Acad. Sci. USA 84:1649.[Abstract/Free Full Text]
-
Clayton, L. K., M. Sieh, D. A. Pious, E. L. Reinherz. 1989. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature 339:548.[Medline]
-
Lamarre, D., A. Ashkenazi, S. Fleury, D. F. Smith, R.-P. Sekaly, D. J. Capon. 1989. The MHC-binding and gp120-binding functions of CD4 are separable. Science 245:743.[Abstract/Free Full Text]
-
Bowman, M. R., K. D. MacFerrin, S. L. Schreiber, S. J. Burakoff. 1990. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 87:9052.[Abstract/Free Full Text]
-
Piatier-Tonneau, D., L.-N. Gastinel, G. Moussy, B. Benichou, F. Amblard, P. Vaigot, C. Auffray. 1991. Mutations in the D strand of the human CD4 V1 domain affect CD4 interactions with the human immunodeficiency virus envelope glycoprotein gp120 and HLA class II antigens similarly. Proc. Natl. Acad. Sci. USA 88:6858.[Abstract/Free Full Text]
-
Moebius, U., P. Pallai, S. C. Harrison, E. L. Reinherz. 1993. Delineation of an extended surface contact area on human CD4 involved in class II major histocompatibility complex binding. Proc. Natl. Acad. Sci. USA 90:8259.[Abstract/Free Full Text]
-
Moebius, U., L. K. Clayton, S. Abraham, A. Diener, J. J. Yunis, S. C. Harrison, E. L. Reinherz. 1992. Human immunodeficiency virus gp120 binding C'C'' ridge of CD4 domain 1 is also involved in interaction with class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 89:12008.[Abstract/Free Full Text]
-
Houlgatte, R., P. Scarmato, S. El Marhomy, M. Martin, M. Ostankovitch, S. Lafosse, A. Vervisch, C. Auffray, D. Platier-Tonneau. 1994. HLA class II antigens and HIV envelope glycoprotein gp120 bind to the same face of CD4. J. Immunol. 152:4475.[Abstract]
-
Kaufman, J., J. Salomonsen, M. Flajnik. 1994. Evolutionary conservation of MHC class I and class II molecules-different yet the same. Semin. Immunol. 6:411.[Medline]
-
Fleury, S., S. Meloche, S.-E. Ryu, C. Cantin, W. A. Hendrickson, R.-P. Sekaly. 1991. Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site. Cell 66:1037.[Medline]
-
Fleury, S., B. Huang, A. Zerbib, G. Croteau, E. O. Long, R.-P. Sekaly. 1996. Mutations in human CD4 impair the functional interaction with different human and mouse class II isotypes and alleles. J. Immunol. 156:1848.[Abstract]
-
Clayton, L. K., R. E. Hussey, R. Steinbrich, H. Ramachandran, Y. Husain, E. L. Reinherz. 1988. Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding. Nature 335:363.[Medline]
-
Peterson, A., B. Seed. 1988. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 54:65.[Medline]
-
Arthos, J., K. C. Deen, M. A. Chaikin, J. A. Fornwald, G. Sathe, Q. J. Sattentau, P. R. Clapham, R. A. Weiss, J. S. McDougal, C. Pietropaolo, et al 1989. Identification of the residues in human CD4 critical for the binding of HIV. Cell 57:469.[Medline]
-
Ruy, S.-E., P. D. Kwong, A. Truneh, T. G. Porter, J. Arthos, M. Rosenberg, X. Dai, N. Xuong, R. Axel, R. W. Sweet, et al 1990. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 29:419.
-
Askenachi, A., L. G. Presta, S. A. Marsters, T. R. Camerato, K. A. Rosenthal, B. M. Fendly, D. J. Capon. 1990. Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis. Proc. Natl. Acad. Sci. USA 87:7150.[Abstract/Free Full Text]
-
Turner, J. M., M. H. Brodsky, B. A. Irving, S. D. Levin, R. M. Perlmutter, D. R. Littman. 1990. Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell 60:755.[Medline]
-
Veillette, A., M. J. H. Ratcliffe. 1991. Avian CD4 and CD8 interact with a cellular tyrosine protein kinase homologous to mammalian p56lck. Eur. J. Immunol. 21:397.[Medline]
-
Gratton, S., X.-J. Yao, S. Venkatesan, E. A. Cohen, R.-P. Sekaly. 1996. Molecular analysis of the cytoplasmic domain of CD4. J. Immunol. 157:3305.[Abstract]
This article has been cited by other articles:

|
 |

|
 |
 
K. J. Laing, J. J. Zou, M. K. Purcell, R. Phillips, C. J. Secombes, and J. D. Hansen
Evolution of the CD4 Family: Teleost Fish Possess Two Divergent Forms of CD4 in Addition to Lymphocyte Activation Gene-3
J. Immunol.,
September 15, 2006;
177(6):
3939 - 3951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Pancer, W. E. Mayer, J. Klein, and M. D. Cooper
Prototypic T cell receptor and CD4-like coreceptor are expressed by lymphocytes in the agnathan sea lamprey
PNAS,
September 7, 2004;
101(36):
13273 - 13278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ozinsky, D. M. Underhill, J. D. Fontenot, A. M. Hajjar, K. D. Smith, C. B. Wilson, L. Schroeder, and A. Aderem
The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors
PNAS,
November 22, 2000;
(2000)
250476497.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Ozinsky, D. M. Underhill, J. D. Fontenot, A. M. Hajjar, K. D. Smith, C. B. Wilson, L. Schroeder, and A. Aderem
The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors
PNAS,
December 5, 2000;
97(25):
13766 - 13771.
[Abstract]
[Full Text]
[PDF]
|
 |
|